October 11, 2007 C-Path and Ventana Medical Systems to Collaborate The Critical Path Institute (C-Path) and Ventana Medical Systems, Inc. (Ventana) (NASDAQ: VMSI) today released additional informat
October 11, 2007 C-Path Awarded Grant to Continue Drug Safety Work The Critical Path Institute (C-Path) announced the receipt of a $4 million grant from the Agency for Healthcare Research and Quali
October 10, 2007 Arizona State Governor Janet Napolitano Awards C-Path with the 2007 Arizona Innovation Award Thanks to C-Path’s role as an independent, neutral third party, it has been successful in bringing together scientists from
August 10, 2007 Science Foundation Arizona Announces $10 Million in Grants to Fund Research Collaboration With Industry Science Foundation Arizona (SFAz), through its Strategic Research Group (SRG) program, today announced that it is granting nearly
May 11, 2007 C-Path Makes Progress to Safely Speed Medical Discoveries to Market William Mattes of C-Path spoke at the Arizona Pavillion May 8th 2007 about the Predictive Safety Testing Consortium.
May 11, 2007 The Predictive Safety Testing Consortium enables companies to share and validate safety biomarkers. To address the issues surrounding a decade-long decrease in the number of new drug approvals, the U.S. Food and Drug Administratio
April 11, 2007 Pharmaceutical Companies and FDA Making Strides Developing a new drug is a costly and time-intensive venture. It often takes years to safely develop, test, and ultimately gain Fo
March 11, 2007 C-Path Adopts Rosetta Resolver® System for the PSTC Rosetta Biosoftware announced today that The Critical Path Institute (C-Path) adopted the Rosetta Resolver® system for C-PathR
March 10, 2007 Raymond Woosley, M.D., Ph.D., Provides Expert Testimony in Congressional Hearings President and CEO of The Critical Path Institute (C-Path) provided testimony and answered questions about drug development yesterd
November 11, 2006 Tucson Nonprofit Seeks to Get Cures to Patients Faster A little-noticed 2004 report from the Food and Drug Administration contained a bombshell. Although spending on research and develo